TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 150 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $28,421,085 | +133.7% | 1,263,721 | +118.5% | 1.82% | +151.8% |
| Q4 2022 | $12,160,976 | +25.0% | 578,268 | +46.5% | 0.72% | +27.6% |
| Q3 2022 | $9,725,000 | +88.8% | 394,678 | +85.6% | 0.57% | +31.9% |
| Q2 2022 | $5,151,000 | -69.6% | 212,593 | -67.7% | 0.43% | -66.7% |
| Q1 2022 | $16,963,000 | -47.5% | 658,249 | -36.8% | 1.29% | -31.8% |
| Q4 2021 | $32,308,000 | +204.7% | 1,040,858 | +138.0% | 1.89% | +200.5% |
| Q3 2021 | $10,604,000 | – | 437,280 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 895,821 | $8,008,640 | 3.99% |
| Deep Track Capital, LP | 7,370,000 | $65,887,800 | 2.54% |
| VR Adviser, LLC | 2,623,677 | $23,455,672 | 2.47% |
| Sio Capital Management, LLC | 884,770 | $7,909,844 | 2.45% |
| Kynam Capital Management, LP | 957,502 | $8,560,068 | 1.40% |
| MPM BioImpact LLC | 552,846 | $4,942,443 | 1.32% |
| ARMISTICE CAPITAL, LLC | 7,500,000 | $67,050,000 | 1.03% |
| Parkman Healthcare Partners LLC | 577,494 | $5,162,796 | 0.95% |
| Tri Locum Partners LP | 251,702 | $2,250,216 | 0.72% |
| Cheyne Capital Management (UK) LLP | 26,200 | $234,228 | 0.68% |